| Randomized control trial on the effectiveness of collagen cross-linking on bullous keratopathy BNK Choy, ALK Ng, MM Zhu, CC Liu, S Xu, JSM Lai Cornea 39 (11), 1341-1347, 2020 | 11 | 2020 |
| Combination of multiple functional markers to improve diagnostic accuracy H Ma, J Yang, S Xu, C Liu, Q Zhang Journal of Applied Statistics 49 (1), 44-63, 2022 | 5 | 2022 |
| Joint model-free feature screening for ultra-high dimensional semi-competing risks data S Lu, X Chen, S Xu, C Liu Computational Statistics & Data Analysis 147, 106942, 2020 | 5 | 2020 |
| Functional data modeling and hypothesis testing for longitudinal alzheimer genome-wide association studies Y Li, I Xu, C Liu Modern Statistical Methods for Health Research, 353-379, 2021 | 4 | 2021 |
| An efficient algorithm for joint feature screening in ultrahigh-dimensional Cox’s model X Chen, CC Liu, S Xu Computational Statistics 36 (2), 885-910, 2021 | 3 | 2021 |
| Subgroup analysis for functional partial linear regression model H Ma, C Liu, S Xu, J Yang Canadian Journal of Statistics 51 (2), 559-579, 2023 | 2 | 2023 |
| Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparison M Shadman, A Tedeschi, L Mohseninejad, K Yang, N Lamanna, S Xu, ... Blood Cancer Journal 14 (1), 77, 2024 | 1 | 2024 |
| Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison M Shadman, A Tedeschi, L Mohseninejad, K Yang, N Lamanna, S Xu, ... Blood 142, 4655, 2023 | 1 | 2023 |
| Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or … Y Song, K Zhou, S Yang, J Hu, D Zou, S Gao, L Pan, T Wang, H Yang, ... Investigational New Drugs 41 (4), 606-616, 2023 | 1 | 2023 |
| Minimax Powerful Functional Analysis of Covariance Tests with Application to Longitudinal Genome‐Wide Association Studies W Zhu, S Xu, C Liu, Y Li Scandinavian Journal of Statistics, 2022 | 1 | 2022 |
| Zanubrutinib Versus Other Bruton Tyrosine Kinase Inhibitors in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Multilevel Network Meta-Regression M Shadman, W Bouwmeester, L Mohseninejad, S Xu, M Jevdjevic, ... EHA, 2024 | | 2024 |
| Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma B Shah, S Challagulla, S Xu, R Williams, S Ren, T Srivastava, R Gautam, ... EHA, 2024 | | 2024 |
| Efficacy and Safety of Zanubrutinib Versus Venetoclax+ Ibrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison T Munir, L Mohseninejad, P Rakonczai, S Xu, K Yang, A Cohen, R Vezan, ... EHA, 2024 | | 2024 |
| Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-Adjusted Indirect Comparison (MAIC) M Shadman, JR Brown, R Williams, L Mohseninejad, K Yang, ... ICHM, 2024 | | 2024 |
| Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison T Munir, L Mohseninejad, S Xu, M Jevdjevic, W Bouwmeester, K Yang Blood 142, 6522, 2023 | | 2023 |
| Indirect Comparison of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL): An Updated Analysis with Long-Term … Y Song, K Zhou, D Li, J Hu, D Zou, S Gao, H Yang, H Zhang, J Ji, W Xu, ... Blood 142, 1682, 2023 | | 2023 |
| Comparison of likelihood ratio tests in post-marketing safety surveillance PAN Zhemin, XU Sheng, Z Yi, C Chenxin, LIU Yongmei, Z Pengpeng, ... Chinese Journal of Pharmacovigilance 20 (6), 655, 2023 | | 2023 |
| SA59 Literature Review of Statistical Methods Comparisons through Simulations When Using External Control Arm for Regulatory or HTA Submissions B Yue, K Lu, S Xu, S Liao Value in Health 26 (6), S407, 2023 | | 2023 |
| 利用真实世界数据的上市后药品安全监测的统计学方法综述 徐圣， 王锴， 廖珊妹 中国食品药品监管, 2021 | | 2021 |
| 真实世界研究的方法学进展 廖珊妹， 张小娟， 张晓薇， 徐圣， 苏岭 中国食品药品监管, 2021 | | 2021 |
